Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shunya Nakashita
Prediction of Anemia in Triple Therapy With Peginterferon ^|^alpha;-2b, Ribavirin, and Telaprevir for Patients With Chronic Hepatitis C From the Viewpoint of Renal Function
Acta Hepatologica Japonica
Hepatology
Related publications
Renal Dysfunction With Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin Therapy
Acta Hepatologica Japonica
Hepatology
Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection
Eastern Mediterranean Health Journal
Medicine
Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
Gastroenterology
Hepatology
Gastroenterology
Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C
Internal Medicine
Internal Medicine
Medicine
Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment With Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients
The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C
Gastroenterology
Hepatology
Gastroenterology
Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C
Gut
Gastroenterology
Prediction of Treatment Efficacy and Telaprevir-Resistant Variants After Triple Therapy in Patients Infected With Hepatitis C Virus Genotype 1
Journal of Clinical Microbiology
Microbiology
